Local Advanced Rectal Cancer
Showing 1 - 25 of >10,000
Rectal Cancer Trial in Chongqing (CIETAI-R)
Recruiting
- Rectal Cancer
- CIETAI-R
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
Jul 21, 2023
Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal
Recruiting
- Rectal Cancer
- +6 more
-
Wuhan, Hubei, China
- +1 more
Jul 12, 2022
Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course
Recruiting
- Locally Advanced Rectal Cancer
- Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
- Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Apr 25, 2023
Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- split-course hypofraction radiotherapy
- +3 more
-
Fuzhou, Fujian, ChinaPan Chi
Jul 23, 2023
Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104 injection
- +3 more
- (no location specified)
Apr 4, 2023
Organ Preservation, Rectal Cancer, Quality of Life Trial in Netherlands (Contact x-ray brachytherapy, Local excision)
Recruiting
- Organ Preservation
- +3 more
- Contact x-ray brachytherapy
- Local excision
-
Leeuwarden, Friesland, Netherlands
- +6 more
Mar 14, 2023
Rectal Cancer, Adenocarcinoma, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Madrid (neoadjuvant treatment)
Completed
- Rectal Cancer, Adenocarcinoma
- +4 more
- neoadjuvant treatment
-
Madrid, SpainHospital La Princesa
Aug 8, 2022
Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))
Recruiting
- Rectal Cancer
- mFOLFOX (neoadjuvant)
- +6 more
-
Mannheim, GermanyUnversity Hospital Mannheim
Aug 12, 2022
Rectal Cancer, Rectum Tumor Trial (Transanal local excision)
Not yet recruiting
- Rectal Cancer
- Rectum Neoplasm
- Transanal local excision
- (no location specified)
Jun 22, 2023
Rectal Cancer Trial in Taipei (Surgery)
Recruiting
- Rectal Cancer
- Surgery
-
Taipei, TaiwanJin-Tung LIANG
Jul 27, 2023
Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 5, 2023
MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)
Not yet recruiting
- MSS
- Rectal Cancer
- Sintilimab with Interleukin-2
- (no location specified)
Nov 1, 2023
Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)
Not yet recruiting
- Locally Advanced Rectal Cancer
- capecitabine
- +3 more
-
Beijing, China
- +1 more
Sep 21, 2023
Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy
Recruiting
- Locally Advanced Rectal Cancer
- Locally Recurrent Rectal Cancer
- Intraoperative Electron Radiotherapy (IOERT)
- Extended Margin Surgery
-
Southampton, Hampshire, United KingdomUniversity Hospital Southampton NHS Foundation Trust
May 24, 2023
Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)
Not yet recruiting
- Rectal Cancer
- CapeOX + cetuximab
- +2 more
- (no location specified)
Sep 12, 2023
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?
Not yet recruiting
- Locally Advanced Rectal Cancer
- +2 more
- nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Aug 11, 2023
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and
Not yet recruiting
- Colorectal Neoplasms
-
Beijing, Xicheng Dis, ChinaBeijing Friendship Hospital, Capital medical University
Sep 5, 2023
Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)
Not yet recruiting
- Rectal Cancer
- Trifluridine/Tipiracil
- intensity-modulated radiotherapy
- (no location specified)
Jul 27, 2023
Neoadjuvant Envafolimab in Resectable and Locally Advanced
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- MSI-High
- (no location specified)
Dec 9, 2022
Locally Advanced Rectal Carcinoma Trial (Cadonilimab Injection, Short-course radiotherapy, Consolidation chemo)
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Cadonilimab Injection
- +2 more
- (no location specified)
Mar 19, 2023
Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)
Not yet recruiting
- Colorectal Cancer
- Serplulimab + FOLFOXIRI
- Radiation therapy
- (no location specified)
Oct 24, 2023
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Locally Advanced Rectal Cancer, Older People Trial in Belgium (radiation, drug, procedure, combination product)
Not yet recruiting
- Locally Advanced Rectal Cancer
- Older People
- Short course radiotherapy
- +3 more
-
Edegem, Antwerpen, Belgium
- +12 more
Sep 18, 2023